Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Multifaceted role of EZH2 in breast and prostate tumorigenesis

(2013) Gauri Deb et al.   Epigenetics

Heterogeneous epigenetic regulation ofTIMP3in prostate cancer

(2012) Toshiaki Shinojima et al.   Epigenetics

Epigallocatechin gallate induce cell death and apoptosis in triple negative breast cancer cells Hs578T

(2012) Cornelia Braicu et al.   JOURNAL OF DRUG TARGETING

The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells

(2012) Yong Jae Shin et al.   PLoS One

Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases

(2011) V. S. Thakur et al.   CARCINOGENESIS

(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells

(2011) S. R. Choudhury et al.   CARCINOGENESIS

The Chemopreventive and Chemotherapeutic Potentials of Tea Polyphenols

(2011) Vijay S. Thakur et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFκB and AP-1 in the human breast cancer cell line MDA-MB-231

(2010) Triparna Sen et al.   ANTI-CANCER DRUGS

The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity

(2010) Keith Brew et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

(–)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells

(2010) Fulvia Farabegoli et al.   BIOSCIENCE REPORTS

5-azacytidine treatment reorganizes genomic histone modification patterns

(2010) Vitalina M. Komashko et al.   Epigenetics

Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3

(2009) L Zhang et al.   CANCER GENE THERAPY

The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival

(2009) S. Balasubramanian et al.   CARCINOGENESIS

CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells

(2009) Xiaojing Yang et al.   PLoS One

Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells

(2008) K Kato et al.   BRITISH JOURNAL OF CANCER

Tube Travel: The Role of Proteases in Individual and Collective Cancer Cell Invasion

(2008) P. Friedl et al.   CANCER RESEARCH

The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis

(2008) William Cruz-Munoz et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation

(2008) Satoshi Fujii et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7

(2008) Triparna Sen et al.   LIFE SCIENCES